INTACT THERAPEUTICS — National Science Foundation SBIR Phase I: BM
INTACT THERAPEUTICS — SBIR Phase I award from National Science Foundation.
- Amount
- $224,999
- Agency
- National Science Foundation
- Program / Phase
- SBIR · Phase I
- Topic
- BM
- NAICS
- —
- Place of performance
- CA
- Period
- 2020-08-15 → 2021-04-30
Description
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop an innovative method to treat upper gastrointestinal bleeding (UGIB). UGIB results in more than 550,000 hospitalizations per year in th